Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?
J Thorac Dis
.
2018 Jul;10(Suppl 18):S2114-S2118.
doi: 10.21037/jtd.2018.06.114.
Authors
Giandomenico Roviello
1
,
Marco Imperatori
1
,
Michele Aieta
1
,
Francesco Sollitto
2
,
Matteo Landriscina
3
4
Affiliations
1
Medical Oncology Unit, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
2
Thoracic Surgery, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
3
Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
4
Medical Oncology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
PMID:
30123536
PMCID:
PMC6072936
DOI:
10.21037/jtd.2018.06.114
No abstract available
Publication types
Editorial
Comment